EPB0131	CD4+ T cell recovery in HIV/HCV co-infected patients following HCV treatment	E-poster	Co-infections (including opportunistic infections)
EPB0132	Magnitude of opportunistic infections among people diagnosed with advanced HIV disease in routine healthcare and their one-year outcomes in Tanzania	E-poster	Co-infections (including opportunistic infections)
EPB0133	The impact of HIV on mortality and recurrence of rifampicin-resistant tuberculosis after successful treatment with second-line regimens: a retrospective cohort study in South Africa	E-poster	Co-infections (including opportunistic infections)
EPB0134	Integrase inhibitor-based antiretroviral treatment does not increase the risk of TB-IRIS in people with HIV treated for tuberculosis: findings from the Reflate TB2 randomized trial	E-poster	Co-infections (including opportunistic infections)
EPB0135	Standard biopsy with high-resolution anoscopy could miss potentially precancerous lesions	E-poster	Co-infections (including opportunistic infections)
EPB0136	Dynamics of cellular senescence markers after HCV elimination spontaneously or by DAAs in people living with HIV	E-poster	Co-infections (including opportunistic infections)
EPB0137	Clinical presentation and outcomes of HIV-associated opportunistic central nervous system infections in the Indonesian national referral hospital: a prospective study	E-poster	Co-infections (including opportunistic infections)
EPB0138	One-dose versus accelerated two-dose schedule for booster HAV vaccination among people living with HIV after primary HAV vaccination	E-poster	Co-infections (including opportunistic infections)
EPB0139	Association between high-risk human papillomavirus infections and cervical cytology results among women living with HIV in Kenya	E-poster	Co-infections (including opportunistic infections)
EPB0140	High prevalence of latent tuberculosis infection among people living with HIV in Thailand, 2022	E-poster	Co-infections (including opportunistic infections)